Loading...

Provexis plc

PXS.LLSE
Healthcare
Drug Manufacturers - Specialty & Generic
£0.75
£0.00(0.00%)

Provexis plc (PXS.L) Company Profile & Overview

Explore Provexis plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Provexis plc (PXS.L) Company Profile & Overview

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOIan Ford BA ACA,

Contact Information

44 7490 391 888
2 Blagrave Street, Reading, RG1 1AZ

Company Facts

2 Employees
IPO DateJun 28, 2004
CountryGB
Actively Trading

Frequently Asked Questions

;